SpaceX Surpasses Amazon in Market Value as Post-IPO Rally Accelerates 
Kingboard Holdings Shares Surge After HK$11.77 Billion Block Trade to Expand PCB and AI Supply Chain Business 
U.S. Reinstates Sanctions on U.N. Expert Francesca Albanese Amid Legal Battle 
TrumpRx Expands Discount Drug Access With 600 Generic Medications 
Bayer Rules Out Monsanto Spin-Off as Roundup Lawsuits Continue to Mount 
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern 
U.S. Supreme Court to Review Trump Administration Appeal on Immigrant Detention Without Bond Hearings 
Trump Team Rejects BBC Financial Data Request in $10B Lawsuit 
Brazil Supreme Court Convicts Eduardo Bolsonaro Over U.S. Lobbying Efforts 
Sigma Healthcare Shares Jump After Exiting Boots Acquisition Process 
Roku Explores Sale Options as Interest Grows in Streaming and Ad Business 
Elon Musk Becomes World's First Trillionaire After SpaceX IPO Surge 
The four types of dementia most people don’t know exist 
UK Banks Report Surge in APP Fraud Losses as Pressure Mounts on Meta and Tech Platforms 
Trump Administration Urges Judge to Allow UFC Event on White House Lawn 
Microsoft Taps AWS to Support GitHub Amid AI Coding Boom 
On Monday, a U.S. appeals court ruled in favor of 3M, E.I. du Pont de Nemours and Co, and other manufacturers of "forever chemicals." The court rejected a lower court's ruling, allowing approximately 11.8 million Ohio residents to sue the companies.
Reuters noted that the ruling relieves considerable legal pressure placed on the chemical manufacturers to settle the plaintiffs' claims.
Court Ruling Questions Class Action Suit's Validity
According to Yahoo, Lead plaintiff Kevin Hardwick's complaint against the manufacturers faced scrutiny from the court. The appeals court found his complaint to be overly broad and lacking evidence that the per- and polyfluoroalkyl substances (PFAS) detected in his body could be directly attributed to the defendants.
The court emphasized that the complaint targeted the collective actions of the companies rather than individual responsibility. Notably, the case involved just 10 out of thousands of companies involved in PFAS manufacturing.
The lower court's approval of the class action suit has been vacated, and the court instructed the dismissal of Hardwick's lawsuit. The lawsuit aimed to hold the companies accountable for the health impacts of PFAS exposure and sought to establish a fund to monitor Ohio residents.
Additionally, Hardwick's request for the companies to fund studies on the health effects of PFAS was denied. These forever chemicals, commonly found in consumer products, have been linked to cancer and other diseases.
Robert Bilott, attorney for Hardwick, expressed disappointment with the court's decision. He stated that it contradicts what is known about the history of PFAS manufacturing in the United States. Bilott's legal team is currently evaluating whether to appeal the ruling further.
The Persistence and Prevalence of Forever Chemicals
PFAS substances earned the nickname "forever chemicals" due to their resistance to breaking down in nature or in the human body. The growing number of lawsuits filed against 3M, DuPont, and other manufacturers in recent years reflect concerns over alleged PFAS contamination.
In June, 3M agreed to pay $10.3 billion to settle hundreds of claims regarding public drinking water pollution caused by PFAS. Furthermore, Chemours Co, DuPont de Nemours Inc, and Corteva reached a similar settlement worth $1.19 billion with U.S. water providers.
Photo: 3M News Center
